Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
FOLH1 expression
i
Other names:
FOLH1, FOLH, GCP2, GCPII, NAALAD1, NAALAdase, PSM, PSMA, Folate hydrolase 1, prostate-specific membrane antigen
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
2346
Related biomarkers:
Expression
‹
›
Associations
(3)
News
Trials
Search handles
@Dr_RaviMadan
@NimaSharifiMD
@OncHahn
@koshkin85
@radiolobt
Search handles
@Dr_RaviMadan
@NimaSharifiMD
@OncHahn
@koshkin85
@radiolobt
Filter by
Latest
8ms
PSMA-targeted radioligand therapy and #LiquidBiopsy characterizing #PSMA expression in men with metastatic castration-resistant #ProstateCancer. @AarmstrongDuke @DukeCancer joins @AndreaMiyahira @PCFnews to discuss the #PROPHECY trial on UroToday > https://t.co/tTiFnUVJOv (@urotoday)
8 months ago
Liquid biopsy • Metastases
|
FOLH1 (Folate hydrolase 1)
|
FOLH1 expression
9ms
PSMA-targeted radioligand therapy and #LiquidBiopsy characterizing #PSMA expression in men with metastatic castration-resistant #ProstateCancer. @AarmstrongDuke @DukeCancer joins @AndreaMiyahira @PCFnews to discuss the #PROPHECY trial on UroToday > https://t.co/tTiFnUVJOv (@urotoday)
9 months ago
Liquid biopsy • Metastases
|
FOLH1 (Folate hydrolase 1)
|
FOLH1 expression
11ms
PSMA expression is not equal to PSMA-PET uptake level (SUV). In late stage mCRPC, intrapatient heterogeneity of PSMA SUV is common and whether the target we treat is the driver disease for death is still under investigation (and may not characterized by single imaging feature). (@yao_zhu_sh)
11 months ago
Clinical
|
FOLH1 (Folate hydrolase 1)
|
FOLH1 expression
12ms
Complex regulation and heterogeneity of PSMA expression in CRPC (seems to be lower in liver metastasis,independent of tumor AR or neuroendocrine features but, without a constant pattern). Congrats @mishabeltran (@mjuanfi81)
12 months ago
FOLH1 (Folate hydrolase 1)
|
FOLH1 expression
1year
Excited to share our manuscript on the development and validation of a CTC liquid biopsy of PSMA expression in men with metastatic prostate cancer in @CCR_AACR: https://t.co/V7MZxsOMaI @DukeCancer @DukeGUCancer @EpicSciences (@AarmstrongDuke)
1 year ago
Liquid biopsy • Metastases • Biopsy
|
FOLH1 (Folate hydrolase 1)
|
FOLH1 expression
over1year
Nice work by the @mishabeltran lab exploring PSMA expression and regulation in CRPC and NEPC. Roles for TF beyond AR in regulation of PSMA @DanaFarber_GU (@OncHahn)
over 1 year ago
FOLH1 (Folate hydrolase 1)
|
FOLH1 expression
over1year
This paradigm & this paper is only for newly diagnosed or recurrent disease. So I’ll defer to the data in #mCRPC with #LuPSMA. But data from @asco mtg suggests higher SUV/thus psma expression respond better. #ProstateCancer (@Dr_RaviMadan)
over 1 year ago
FOLH1 (Folate hydrolase 1)
|
FOLH1 expression
over1year
I 💯 agree with evaluation using FDG PET as it will provide additional information in this prostate cancer that has heterogeneous PSMA expression. I am curious, are the FDG positive tumors that are PSMA heterogeneous or negative more aggressive? @GabiSpil @ThomasNgImaging (@MariamAboian)
over 1 year ago
FDG PET
|
FOLH1 (Folate hydrolase 1)
|
FOLH1 expression
over1year
Nice summary of combo trials with PSMA-directed RLTs in metastatic #prostatecancer We’re excited to open our @PCFnews supported study @UCSFCancer with @thomashopemd using Abemaciclib to upregulate PSMA expression prior to Pluvicto in #mcrpc @PCF_Science @UCSFimaging (@koshkin85)
over 1 year ago
FOLH1 (Folate hydrolase 1)
|
FOLH1 expression
|
Verzenio (abemaciclib) • Pluvicto (lutetium Lu 177 vipivotide tetraxetan)
almost2years
Assessment of malignancy and PSMA expression of uncertain bone foci in PSMA-1007 PET/CT for #prostatecancer-a single-center experience of PET-guided biopsies https://t.co/VZedwOwNNa #molecularimaging #CancerResearch #MedTwitter (@radiolobt)
almost 2 years ago
Clinical
|
FOLH1 (Folate hydrolase 1)
|
FOLH1 expression
2years
PSMA PET signal in lymph nodes should be used as a binary finding for staging and not to estimate the degree of PSMA expression. https://t.co/t8W3cTMlru #PersonalizedMedicine #NucMed #ProstateCancer @JAMAOnc @thomashopemd @CalaisJeremie (@JournalofNucMed)
2 years ago
FOLH1 (Folate hydrolase 1)
|
FOLH1 expression
2years
Fantastic talk on PSMA expression and NE/AR low prostate cancer by @mishabeltran. Many important questions to be answered… #GU22 (@wandering_gu)
2 years ago
FOLH1 (Folate hydrolase 1)
|
FOLH1 expression
2years
Great talk by Johannes Czernin @UCLAJCCC on prostate cancer responsiveness to PSMA targeted therapy. Resistance mechanisms include p53 mutations, absence of PSMA expression, perhaps DDR mutations @PCF_Science #GU22 @ASCO (@NimaSharifiMD)
2 years ago
TP53 (Tumor protein P53) • FOLH1 (Folate hydrolase 1)
|
TP53 mutation • FOLH1 expression
over2years
What's behind 68 Ga-PSMA-11 uptake in primary prostate cancer PET? Investigation of histopathological parameters and IHC PSMA expression patterns https://t.co/hn1qRvJqKz "nice work which aims to explain the biology of the prostatic uptake patterns at PSMA PET/CT" #CancerResearch (@radiolobt)
over 2 years ago
FOLH1 (Folate hydrolase 1)
|
FOLH1 expression
over2years
What's behind 68 Ga-PSMA-11 uptake in primary prostate cancer PET? Investigation of histopathological parameters and immunohistochemical PSMA expression patterns https://t.co/hn1qRvJqKz "very nice work aiming to explain biology of PMSA uptake at PET/CT scans" #CancerResearch (@radiolobt)
over 2 years ago
FOLH1 (Folate hydrolase 1)
|
FOLH1 expression
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login